January 31, 2022
2 mins read

NHS expands Covid vaccines to at-risk 5 to 11-year-old kids

The NHS had earlier opened up vaccines for the over 12 age group and said it has delivered over 3.5 million vaccinations to people aged 12-17, including over 2.4 million first doses…reports Asian Lite News

The UK’s National Health Service (NHS) on Sunday expanded its COVID-19 vaccination programme to cover vulnerable children aged five to 11 years.

Eligible children include those with diabetes, immunosuppression, learning disabilities, and other serious conditions that place them at high risk from COVID-19.

NHS England said nearly 500,000 eligible children in England are set to receive their first dose of a COVID vaccine in line with advice set out by the Joint Committee on Vaccination and Immunisation (JCVI).

We know vaccines give significant protection against severe illness from COVID including the Omicron variant, so it is important that our youngest and most at-risk get protected, said Dr Nikki Kanani, an Indian-origin GP and deputy lead for NHS vaccination programme.

The NHS is now vaccinating the most at risk 511-year-olds ensuring they get their vital dose of protection. Thousands of young people are still getting protected every day with millions vaccinated so far and we are asking parents not to delay coming forward as soon as the NHS contacts you, please come forward so the NHS can protect their youngest against the virus, she said.

The NHS had earlier opened up vaccines for the over 12 age group and said it has delivered over 3.5 million vaccinations to people aged 12-17, including over 2.4 million first doses.

UK Vaccines Minister Maggie Throup said: I would like parents and guardians to be reassured that no new vaccine for children would have been approved unless the expected standards of safety, quality and effectiveness had been met.

I encourage as many as possible to make sure they get their child the jab when contacted – the paediatric vaccine will offer the best possible protection for your child.

In line with procedures, patient information is sent out to parents and guardians with information on the COVID-19 vaccination. Parents and guardians are asked to attend with their children and are asked to read the patient information in advance of arriving for their appointment.

Photo Credits: Richard Townshend/ UK Parliament

Eligible children in the youngest cohort will get a second dose eight weeks after their first dose and can’t receive any vaccination until four weeks after a positive test for coronavirus.

Last month, the JCVI also issued updated guidance recommending all 16 and 17-year-olds get a Pfizer/BioNTech booster from three months (91 days) after their second dose. Following the expansion of a third booster vaccine for all 16 and 17-year-olds, over half of the eligible young people in this age group have already received their top-up protection.

ALSO READ-‘We are the NHS’

Previous Story

Baloch situation turning from bad to worse

Next Story

US shutters Afghan embassy

Latest from -Top News

GAZA KILLINGS: War Crime?

Mobile Phone Footage Casts Doubt on Israeli Account of Ambulance Attack in Gaza Newly surfaced mobile phone footage has raised serious questions about the Israeli military’s justification for opening fire on a

Namibia voices concern over US tariffs

AGOA is a non-reciprocal trade arrangement aimed at supporting development in African countries through preferential access to US markets The Namibian government has expressed concern over newly imposed US tariffs, warning that

Uganda, South Sudanese leaders hold talks

Museveni, who is among the guarantors of a 2018 peace agreement that ended a five-year civil war, held closed-door discussions with President Salva Kiir Uganda’s President Yoweri Museveni was expected to meet

Protests across US against Trump

The largest event was at the National Mall in DC, where demonstrators numbered in the tens of thousands People across the US took to the streets on Saturday to oppose what left-leaning

Namibia voices concern over US tariffs

AGOA is a non-reciprocal trade arrangement aimed at supporting development in African countries through preferential access to US markets The Namibian government has expressed concern over newly imposed US tariffs, warning that
Go toTop

Don't Miss

MENTAL HEALTH AT STAKE

Health Secretary Sajid Javed urged to take immediate action as

Indigenous nasal vaccines could be game changer: WHO Chief Scientist

Swaminathan, a paediatrician and clinical scientist, stressed upon the vaccination